Weekly rituximab followed by monthly rituximab treatment for
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study by Seok Jin Kim, Jong Wook Lee, Chul Won Jung, Chang Ki Min, Bin Cho, Ho Jin Shin, Joo Seop Chung, Hawk Kim, Won Sik Lee, Young Don Joo, Deok-Hwan Yang, Hoon Kook, Hyoung Jin Kang, Hyo Seop Ahn, Sung-Soo Yoon, Sang Kyun Sohn, Yoo Hong Min, Woo-Sung Min, Hee-Sook Park, and Jong Ho Won haematol Volume 95(11): 1935 -1942 October 31, 2010 © 2010 by Ferrata Storti Foundation
(A) Treatment schedule and response evaluation. Seok Jin Kim et al. Haematologica 2010; 95: 1935 -1942 © 2010 by Ferrata Storti Foundation
Baseline characteristics of the patients with chronic GVHD. Seok Jin Kim et al. Haematologica 2010; 95: 1935 -1942 © 2010 by Ferrata Storti Foundation
Summary of treatment outcomes in the 37 patients studied. Seok Jin Kim et al. Haematologica 2010; 95: 1935 -1942 © 2010 by Ferrata Storti Foundation
(A) In the ITT analysis of quality of life, patients reported increased scores in six domains (RP, BP, GH, SF, RE and MH) although only the effects on RP and BP were statistically significant (P<0. 05). Seok Jin Kim et al. Haematologica 2010; 95: 1935 -1942 © 2010 by Ferrata Storti Foundation
Rituximab responses according to manifestation or organ involved. Seok Jin Kim et al. Haematologica 2010; 95: 1935 -1942 © 2010 by Ferrata Storti Foundation
Serial changes in serum BAFF and immunoglobulins. Seok Jin Kim et al. Haematologica 2010; 95: 1935 -1942 © 2010 by Ferrata Storti Foundation
- Slides: 7